Beibei Yang

State Key Laboratory Of Bioactive Substance And Function Of Natural Medicines, Peking Union Medical College And Chinese Academy Of Medical Sciences
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Total Synthesis of Artapilosine A and Artapilosine B.

Total Synthesis of Artapilosine A and Artapilosine B.

Journal: Journal of natural products

Published: December 10, 2024

Discovery of Propionic Acid Derivatives with a 5-THIQ Core as Potent and Orally Bioavailable Keap1-Nrf2 Protein-Protein Interaction Inhibitors for Acute Kidney Injury.

Discovery of Propionic Acid Derivatives with a 5-THIQ Core as Potent and Orally Bioavailable Keap1-Nrf2 Protein-Protein Interaction Inhibitors for Acute Kidney Injury.

Journal: Journal of medicinal chemistry

Published: October 10, 2024

Dual-duty NiCo2S4 nanosheet-based solar rechargeable batteries toward multi-scene solar energy conversion and storage.

Dual-duty NiCo2S4 nanosheet-based solar rechargeable batteries toward multi-scene solar energy conversion and storage.

Journal: Nanoscale

Published: June 05, 2023

The Asymmetric Total Synthesis of (-)-Eurothiocin A and Its Enantiomer.

The Asymmetric Total Synthesis of (-)-Eurothiocin A and Its Enantiomer.

Journal: Journal of natural products

Published: February 21, 2022

Surface coating preparation of spherical magnetic materials.

Surface coating preparation of spherical magnetic materials.

Journal: RSC advances

Published: February 07, 2022

Discovery of a Candidate Containing an (S)-3,3-Difluoro-1-(4-methylpiperazin-1-yl)-2,3-dihydro-1H-inden Scaffold as a Highly Potent Pan-Inhibitor of the BCR-ABL Kinase Including the T315I-Resistant Mutant for the Treatment of Chronic Myeloid Leukemia.

Discovery of a Candidate Containing an (S)-3,3-Difluoro-1-(4-methylpiperazin-1-yl)-2,3-dihydro-1H-inden Scaffold as a Highly Potent Pan-Inhibitor of the BCR-ABL Kinase Including the T315I-Resistant Mutant for the Treatment of Chronic Myeloid Leukemia.

Journal: Journal of medicinal chemistry

Published: May 20, 2021

Identification of Novel Tricyclic Benzo[1,3]oxazinyloxazolidinones as Potent Antibacterial Agents with Excellent Pharmacokinetic Profiles against Drug-Resistant Pathogens.

Identification of Novel Tricyclic Benzo[1,3]oxazinyloxazolidinones as Potent Antibacterial Agents with Excellent Pharmacokinetic Profiles against Drug-Resistant Pathogens.

Journal: Journal of medicinal chemistry

Published: March 11, 2021

The mutational landscape of spinal chordomas and their sensitive detection using circulating tumor DNA.

The mutational landscape of spinal chordomas and their sensitive detection using circulating tumor DNA.

Journal: Neuro-oncology advances

Published: February 05, 2021

Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia.

Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia.

Journal: Aging

Published: June 06, 2020

Cytotoxic and Antibacterial Cervinomycins B1-4 from a Streptomyces Species.

Cytotoxic and Antibacterial Cervinomycins B1-4 from a Streptomyces Species.

Journal: Journal of natural products

Published: August 06, 2019

Isarubrolones Containing a Pyridooxazinium Unit from Streptomyces as Autophagy Activators.

Isarubrolones Containing a Pyridooxazinium Unit from Streptomyces as Autophagy Activators.

Journal: Journal of natural products

Published: May 10, 2019

Mapping the scientific research on non-point source pollution: a bibliometric analysis.

Mapping the scientific research on non-point source pollution: a bibliometric analysis.

Journal: Environmental science and pollution research international

Published: September 02, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026